3-(2-Methoxyphenyl)-9-(2-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)thio)ethyl)-3,9-diazaspiro[5.5]undecane

ID: ALA4514100

PubChem CID: 142573449

Max Phase: Preclinical

Molecular Formula: C27H35N5OS

Molecular Weight: 477.68

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccccc1N1CCC2(CCN(CCSc3nnc(-c4ccccc4)n3C)CC2)CC1

Standard InChI:  InChI=1S/C27H35N5OS/c1-30-25(22-8-4-3-5-9-22)28-29-26(30)34-21-20-31-16-12-27(13-17-31)14-18-32(19-15-27)23-10-6-7-11-24(23)33-2/h3-11H,12-21H2,1-2H3

Standard InChI Key:  NCWGEGAYIHJRDE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   22.9061  -19.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6119  -19.5548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3147  -19.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3179  -18.3353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6122  -17.9267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9032  -18.3330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4987  -19.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4987  -19.9634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2040  -20.3679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9093  -19.9634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2040  -18.7335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0230  -17.9270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7299  -18.3391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4382  -17.9331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4407  -17.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7291  -16.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0237  -17.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3160  -16.7047    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.3158  -15.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7916  -20.3730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0833  -19.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0821  -19.1483    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.3661  -18.7639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2590  -17.9528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4548  -17.8076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0682  -18.5276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6335  -19.1177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0996  -17.0719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5611  -16.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2065  -15.6607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3907  -15.5998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9308  -16.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2879  -17.0131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8504  -17.3888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  7 11  1  0
  8  9  1  0
  9 10  1  0
 10  1  1  0
  1 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  4 12  1  0
 17 18  1  0
 18 19  1  0
  8 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 23  2  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 25 28  1  0
 24 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4514100

    ---

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.68Molecular Weight (Monoisotopic): 477.2562AlogP: 4.97#Rotatable Bonds: 7
Polar Surface Area: 46.42Molecular Species: BASEHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.91CX LogP: 4.63CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -1.61

References

1. Reilly SW, Riad AA, Hsieh CJ, Sahlholm K, Jacome DA, Griffin S, Taylor M, Weng CC, Xu K, Kirschner N, Luedtke RR, Parry C, Malhotra S, Karanicolas J, Mach RH..  (2019)  Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs).,  62  (10): [PMID:31021617] [10.1021/acs.jmedchem.9b00412]

Source